Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Stocrin
Active Ingredient(s): Efavirenz 100mg
Dosage Form: Capsule
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Du Pont Pharmaceuticals Company, Garden City, New York, United States of America
Note: This consent is valid for 2 years from 11 November 2001.
Product: Stocrin
Active Ingredient(s): Efavirenz 200mg
Dosage Form: Capsule
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Du Pont Pharmaceuticals Company, Garden City, New York, United States of America
Note: This consent is valid for 2 years from 11 November 2001.
Product: Stocrin
Active Ingredient(s): Efavirenz 50mg
Dosage Form: Capsule
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Du Pont Pharmaceuticals Company, Garden City, New York, United States of America
Note: This consent is valid for 2 years from 11 November 2001.
Dated this 21st day of February 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).